バッテン病治療の世界市場:規模・現状・予測2019-2025

【英語タイトル】Global Batten Disease Treatment Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料(QYR20FB08225)・商品コード:QYR20FB08225
・発行会社(調査会社):QYResearch
・発行日:2019年11月(※2024年版があります。お問い合わせください)
・ページ数:94
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※当調査レポートでは、バッテン病治療の世界市場について調査・分析し、バッテン病治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(作業療法、理学療法)、用途別(幼児NCL、後期幼児NCL、少年NCL、成人NCL)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界のバッテン病治療市場動向
・主要企業別マーケットシェア
・バッテン病治療の種類別市場規模2014-2019
(作業療法、理学療法)
・バッテン病治療の用途別市場規模2014-2019
(幼児NCL、後期幼児NCL、少年NCL、成人NCL)
・バッテン病治療の北米市場:主要企業・種類別/用途別市場規模
・バッテン病治療のヨーロッパ市場:主要企業・種類別/用途別市場規模
・バッテン病治療の中国市場:主要企業・種類別/用途別市場規模
・バッテン病治療の日本国内市場:主要企業・種類別/用途別市場規模
・バッテン病治療の東南アジア市場:主要企業・種類別/用途別市場規模
・バッテン病治療のインド市場:主要企業・種類別/用途別市場規模
・バッテン病治療の中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(BioMarin Pharmaceuticals、Seneb BioSciences, Inc.、ReGenX Biosciences LLC、Amicus Therapeutics、Ionis Pharmaceuticals, Inc.、Celenex, Inc.)
・バッテン病治療の市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...
【レポートの概要】

Batten disease is inherited disorder of the nervous system which begins in childhood.It is also called as neuronal ceroid lipofuscinoses (or NCLs). Batten Disease Treatment is the treatment of this type of disease.In 2018, the global Batten Disease Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Batten Disease Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Batten Disease Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
BioMarin Pharmaceuticals
Seneb BioSciences, Inc.
ReGenX Biosciences LLC
Amicus Therapeutics
Ionis Pharmaceuticals, Inc.
Celenex, Inc.

Market segment by Type, the product can be split into
Occupational Therapies
Physical Therapies

Market segment by Application, split into
Infantile NCL
Late Infantile NCL
Juvenile NCL
Adult NCL

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Batten Disease Treatment status, future forecast, growth opportunity, key market and key players.
To present the Batten Disease Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Batten Disease Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Batten Disease Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Occupational Therapies
1.4.3 Physical Therapies
1.5 Market by Application
1.5.1 Global Batten Disease Treatment Market Share by Application (2019-2025)
1.5.2 Infantile NCL
1.5.3 Late Infantile NCL
1.5.4 Juvenile NCL
1.5.5 Adult NCL
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Batten Disease Treatment Market Size
2.2 Batten Disease Treatment Growth Trends by Regions
2.2.1 Batten Disease Treatment Market Size by Regions (2019-2025)
2.2.2 Batten Disease Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Batten Disease Treatment Market Size by by Players
3.1.1 Global Batten Disease Treatment Revenue by by Players (2014-2019)
3.1.2 Global Batten Disease Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Batten Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Batten Disease Treatment Key Players Head office and Area Served
3.3 Key Players Batten Disease Treatment Product/Solution/Service
3.4 Date of Enter into Batten Disease Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Batten Disease Treatment Market Size by Type (2014-2019)
4.2 Global Batten Disease Treatment Market Size by Application (2014-2019)

5 North America
5.1 North America Batten Disease Treatment Market Size (2014-2019)
5.2 Batten Disease Treatment Key Players in North America
5.3 North America Batten Disease Treatment Market Size by Type
5.4 North America Batten Disease Treatment Market Size by Application

6 Europe
6.1 Europe Batten Disease Treatment Market Size (2014-2019)
6.2 Batten Disease Treatment Key Players in Europe
6.3 Europe Batten Disease Treatment Market Size by Type
6.4 Europe Batten Disease Treatment Market Size by Application

7 China
7.1 China Batten Disease Treatment Market Size (2014-2019)
7.2 Batten Disease Treatment Key Players in China
7.3 China Batten Disease Treatment Market Size by Type
7.4 China Batten Disease Treatment Market Size by Application

8 Japan
8.1 Japan Batten Disease Treatment Market Size (2014-2019)
8.2 Batten Disease Treatment Key Players in Japan
8.3 Japan Batten Disease Treatment Market Size by Type
8.4 Japan Batten Disease Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Batten Disease Treatment Market Size (2014-2019)
9.2 Batten Disease Treatment Key Players in Southeast Asia
9.3 Southeast Asia Batten Disease Treatment Market Size by Type
9.4 Southeast Asia Batten Disease Treatment Market Size by Application

10 India
10.1 India Batten Disease Treatment Market Size (2014-2019)
10.2 Batten Disease Treatment Key Players in India
10.3 India Batten Disease Treatment Market Size by Type
10.4 India Batten Disease Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Batten Disease Treatment Market Size (2014-2019)
11.2 Batten Disease Treatment Key Players in Central & South America
11.3 Central & South America Batten Disease Treatment Market Size by Type
11.4 Central & South America Batten Disease Treatment Market Size by Application

12 International Players Profiles
12.1 BioMarin Pharmaceuticals
12.1.1 BioMarin Pharmaceuticals Company Details
12.1.2 Company Description and Business Overview
12.1.3 Batten Disease Treatment Introduction
12.1.4 BioMarin Pharmaceuticals Revenue in Batten Disease Treatment Business (2014-2019))
12.1.5 BioMarin Pharmaceuticals Recent Development
12.2 Seneb BioSciences, Inc.
12.2.1 Seneb BioSciences, Inc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Batten Disease Treatment Introduction
12.2.4 Seneb BioSciences, Inc. Revenue in Batten Disease Treatment Business (2014-2019)
12.2.5 Seneb BioSciences, Inc. Recent Development
12.3 ReGenX Biosciences LLC
12.3.1 ReGenX Biosciences LLC Company Details
12.3.2 Company Description and Business Overview
12.3.3 Batten Disease Treatment Introduction
12.3.4 ReGenX Biosciences LLC Revenue in Batten Disease Treatment Business (2014-2019)
12.3.5 ReGenX Biosciences LLC Recent Development
12.4 Amicus Therapeutics
12.4.1 Amicus Therapeutics Company Details
12.4.2 Company Description and Business Overview
12.4.3 Batten Disease Treatment Introduction
12.4.4 Amicus Therapeutics Revenue in Batten Disease Treatment Business (2014-2019)
12.4.5 Amicus Therapeutics Recent Development
12.5 Ionis Pharmaceuticals, Inc.
12.5.1 Ionis Pharmaceuticals, Inc. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Batten Disease Treatment Introduction
12.5.4 Ionis Pharmaceuticals, Inc. Revenue in Batten Disease Treatment Business (2014-2019)
12.5.5 Ionis Pharmaceuticals, Inc. Recent Development
12.6 Celenex, Inc.
12.6.1 Celenex, Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Batten Disease Treatment Introduction
12.6.4 Celenex, Inc. Revenue in Batten Disease Treatment Business (2014-2019)
12.6.5 Celenex, Inc. Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details



【掲載企業】

BioMarin Pharmaceuticals、Seneb BioSciences, Inc.、ReGenX Biosciences LLC、Amicus Therapeutics、Ionis Pharmaceuticals, Inc.、Celenex, Inc.

★調査レポート[バッテン病治療の世界市場:規模・現状・予測2019-2025] (コード:QYR20FB08225)販売に関する免責事項を必ずご確認ください。
★調査レポート[バッテン病治療の世界市場:規模・現状・予測2019-2025]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆